Immunogenicity and safety profile of the monovalent A/H1N1 MF59-adjuvanted vaccine in patients affected by cystic fibrosis

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)259-260
Number of pages2
JournalThorax
Volume66
Issue number3
DOIs
Publication statusPublished - Mar 2011

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this